Schedule 13G ownership disclosure

Furiex Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 36106P101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
575,450
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-14-000327
Form type
SC 13G
Filer
Furiex Pharmaceuticals, Inc.
CIK
CIK 1484478
Filed
May 09, 2014
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub